Cancer disease progression and death during the COVID-19 pandemic: A multidisciplinary analysis for the Peruvian setting

Juan Astigueta-Pérez*, Milagros Abad-Licham, Carlos Chávez-Chirinos, Luis Beraun-Milla, Alberto Lachos-Dávila, Elizabeth Diaz-Pérez, Karem Portugal-Valdivia, Paul Pilco Castañeda, Isaías Pérez Alférez, Edward Mezones-Holguín

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

4 Citas (Scopus)

Resumen

Since the COVID-19 pandemic began in China in late 2019, infection from the SARSCoV-2 virus has spread virtually worldwide. This infection has adversely affected several countries; governments have outlined a series of political measures aimed to preserve the health and safety of their populations. In Peru, most actions have prioritised COVID-19 attention, with a subsequent gap in the healthcare facilities needed for other diseases. Cancer, one principal cause of death in the country, is usually diagnosed late. Moreover, in the pandemic context, the prevention and control of cancer have been negatively affected. Therefore, we carried out a multidisciplinary analysis using the Ishikawa diagram to identify the probable factors that contribute to cancer progression and deaths in Peru.

Idioma originalInglés
Número de artículo1098
Publicaciónecancermedicalscience
Volumen14
DOI
EstadoPublicada - ago. 2020

Huella

Profundice en los temas de investigación de 'Cancer disease progression and death during the COVID-19 pandemic: A multidisciplinary analysis for the Peruvian setting'. En conjunto forman una huella única.

Citar esto